Taipei Medical University in Taiwan is located in Taipei's Xinyi District. Founded as Taipei Medical College in 1960, it was renamed as Taipei Medical University in 2000. It underwent the processes to building the foundation, flourishing, expansion and transformation via innovation.

During the past decade, Taipei Medical University conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei Medical University" #1 sponsor was "Taipei Medical University" with 14 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Advagene Biopharma Co. Ltd." with 1 trials sponsored, "Chinook Therapeutics U.S., Inc." with 1 trials sponsored and "Janssen Vaccines & Prevention B.V." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Medical University" #1 collaborator was "Ministry of Science and Technology, Taiwan" with 2 trials as a collaborator, "Taipei Medical University" with 2 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Meiji Co., Ltd." with 1 trials as a collaborator and "TCI Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Taipei Medical University" are "Depressive Disorder, Major" (4 trials), "Chemotherapy Training" (2 trials), "Sarcopenia" (2 trials), "Acute Respiratory Infection" (1 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Taipei Medical University" in a lesser frequency.

Most popular intervention types in "Taipei Medical University" are "Other" (8 trials), "Drug" (6 trials), "Behavioral" (5 trials), "Dietary Supplement" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Aticaprant" (2 trials), "VR training program" (2 trials), "AD17002" (1 trials) and "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taipei Medical University" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Taipei Medical University". undefined are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Taipei Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Taipei Medical University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".